Year: 2019

Chancellor Nicholas S. Zeppos (Daniel Dubois/Vanderbilt University)

VU Chancellor Nicholas S. Zeppos to step down Aug. 15

Vanderbilt University Chancellor Nicholas S. Zeppos announced today that he will step down as the university’s eighth chancellor on Aug. 15 after more than a decade in the role. Zeppos plans to take a yearlong sabbatical before returning to the faculty as professor of law.

Vanderbilt University Medical Center to acquire Tennova Healthcare-Lebanon from Community Health Systems

Leaders of Vanderbilt University Medical Center (VUMC) today announced plans to purchase Tennova Healthcare-Lebanon, a two-campus facility licensed for 245 beds, from subsidiaries of Community Health Systems, Inc. (CHS). A definitive agreement has been signed for the sale of the facility and related businesses, including physician clinic operations and outpatient services, to VUMC.

Cancer’s SOS

Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.

Cardiac dysfunction in DMD

The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

Drug interaction causes hypotension

A muscle relaxing-drug and inhibitors of the metabolic enzyme CYP1A2 interact to cause severely low blood pressure and should not be co-prescribed, Vanderbilt investigators caution.

Unraveling endocytosis

New discoveries by Jason MacGurn and colleagues further understanding of the complex machinery that cells use take up substances from outside the cell.

1 54 55 56 57 58 74